Work

Abstract CT213: Impact of smoking on outcomes with durvalumab following chemoradiotherapy in unresectable Stage III NSCLC (PACIFIC)

Year: 2020

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2020-ct213

Authors: David Planchard, Mustafa Özgüroğlu, Davey Daniel, Augusto Villegas, David Vicente, Shuji Murakami, Rina Hui, Corinne Faivre-Finn, Luis Paz-Ares, Yi-Long Wu, Euan Macpherson, Michael Newton, Phillip Dennis, Scott J. Antonia

Institutions: Institut Gustave Roussy, Istanbul University-Cerrahpaşa, Istanbul University, Tennessee Oncology, Hospital Universitario Virgen Macarena, Kanagawa Cancer Center, The University of Sydney, Westmead Hospital, University of Manchester, The Christie NHS Foundation Trust, Hospital Universitario 12 De Octubre, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, AstraZeneca (United Kingdom), Moffitt Cancer Center

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3082061470

Cites:

Cited by:

Related to: 10